Dong, Qingzhong – Trademark Portfolio

Entity Type: 01

Dong, Qingzhong holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IFZERO and KUPUMP. The owner is based in Shaanxi Province.

No. 10, Shilipu Street, Baqiao District

Shaanxi Province 710000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IFZERO
IFZERO
Registered 2021
KUPUMP
KUPUMP
Registered 2021

Trademark Classifications

Dong, Qingzhong's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Dong, Qingzhong have?

Dong, Qingzhong has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Dong, Qingzhong file in?

Dong, Qingzhong files trademarks across 2 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 10 (Medical Apparatus). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are Dong, Qingzhong's most well-known trademarks?

Dong, Qingzhong's registered trademark portfolio includes well-known marks such as IFZERO and KUPUMP. These are among 2 currently registered trademarks in the portfolio.

What is Dong, Qingzhong's trademark registration success rate?

Dong, Qingzhong has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.